REZALTIMO Trademark

Trademark Overview

On Friday, July 21, 2023, a trademark application was filed for REZALTIMO with the United States Patent and Trademark Office. The USPTO has given the REZALTIMO trademark a serial number of 98095376. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, April 1, 2024. This trademark is owned by Glaxo Group Limited. The REZALTIMO trademark is filed in the Pharmaceutical Products category with the following description:

(Based on Sections 1(b) and 44(e)) Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
rezaltimo

General Information

Serial Number98095376
Word MarkREZALTIMO
Filing DateFriday, July 21, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, April 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Services(Based on Sections 1(b) and 44(e)) Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 21, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Trademark Events

Event DateEvent Description
Tuesday, July 25, 2023NEW APPLICATION ENTERED
Monday, August 21, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 25, 2024ASSIGNED TO EXAMINER
Monday, April 1, 2024NON-FINAL ACTION WRITTEN
Monday, April 1, 2024NON-FINAL ACTION E-MAILED
Monday, April 1, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 2, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED

Related Keywords

rezaltimo treatment preparations pharmaceutical diseases disorders oncological cardiopulmonary musculoskeletal genitourinary cardiovascular